Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Syra Health Corp. Class A Common Stock (SYRA)
USD0.68
+0.14 (+25.81%)
US OTC Healthcare Medical - Care Facilities
Address
1119 Keystone Way North 46032
Carmel, DE, US
Carmel, DE, US
CEO
Gregory R. Alexander
Website
syrahealth.com
IPO
2023-09-29
CIK 1922335 ISIN US87168W2035
Description
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.68
+0.14 (+25.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
76.5K
Beta
3.56
Float Shares
9.33M
Free Float %
82.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.27% | +27.50% | +53.80% | +535.91% | +661.19% | +493.02% | +466.67% | -83.00% | -83.00% | -83.00% | -83.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.68
Ratings Trend (MoM)
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.29
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-9.5% Q1'26: +22.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+85.5% ★ Q1'26: +128.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-7.9% Q1'26: +59.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-12.5% Q1'26: +8.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-144.2% Q1'26: -157.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+63.2% Q1'26: +75.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-0.16× Q1'26: 0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|
| Revenue |
5.52M
est: 6.00M (-8.1%)
|
7.98M
est: 7.99M (-0.1%)
|
| EBITDA |
-2.84M
est: -416.2K (-581.3%)
|
-3.68M
est: -2.35M (-56.8%)
|
| EBIT |
-2.88M
est: -439.6K (-556.2%)
|
-3.74M
est: -2.38M (-57.1%)
|
| Net Income |
-2.94M
est: -3.63M (+19.1%)
|
-3.76M
est: -6.28M (+40.2%)
|
| SGA |
4.01M
est: 3.31M (+21.2%)
|
1.45M
est: 3.53M (-59.1%)
|
| EPS |
-0.60
est: -0.50 (-20.0%)
|
-0.52
est: -0.53 (+1.9%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-473.8K
OE per share TTM
-0.03
Owner's Yield
-8.82%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
3.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
2
Beneficial owners (>5%)
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
57.6K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+57,646
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | Alexander Gregory R. | Officer | A-Award | A | Stock Options | 257,920 | 0.09 | 23.2K | 257,920 | D | ↗ |
| 2025-11-21 | Reddy Vijayapal | Director | A-Award | A | Stock Options | 43,348 | 0.07 | 3.0K | 70,926 | D | ↗ |
| 2025-11-21 | Reddy Avutu | Director | A-Award | A | Stock Options | 43,348 | 0.07 | 3.0K | 70,926 | D | ↗ |
| 2025-11-21 | Paranjape Ketan | Director | A-Award | A | Stock Options | 43,348 | 0.07 | 3.0K | 77,821 | D | ↗ |
| 2025-08-13 | Mereddy Radhika | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-07 | Rogers Sherron | Director | A-Award | A | Stock Options | 9,102 | 0.74 | 6.7K | 20,683 | D | ↗ |
| 2025-01-07 | Reddy Vijayapal | Director | A-Award | A | Stock Options | 12,136 | 0.74 | 9.0K | 27,578 | D | ↗ |
| 2025-01-07 | Reddy Avutu | Director | A-Award | A | Stock Options | 12,136 | 0.74 | 9.0K | 27,578 | D | ↗ |
| 2025-01-07 | Paranjape Ketan | Director | A-Award | A | Stock Options | 15,170 | 0.74 | 11.2K | 34,473 | D | ↗ |
| 2025-01-07 | Dahlem Andrew | Director | A-Award | A | Stock Options | 9,102 | 0.74 | 6.7K | 20,683 | D | ↗ |
| 2024-11-14 | Rogers Sherron | Director | A-Award | A | Stock Options | 11,581 | 0.37 | 4.3K | 11,581 | D | ↗ |
| 2024-11-14 | Reddy Vijayapal | Director | A-Award | A | Stock Options | 15,442 | 0.37 | 5.7K | 15,442 | D | ↗ |
| 2024-11-14 | Reddy Avutu | Director | A-Award | A | Stock Options | 15,442 | 0.37 | 5.7K | 15,442 | D | ↗ |
| 2024-11-14 | Paranjape Ketan | Director | A-Award | A | Stock Options | 19,303 | 0.37 | 7.1K | 19,303 | D | ↗ |
| 2024-11-14 | Dahlem Andrew | Director | A-Award | A | Stock Options | 11,581 | 0.37 | 4.3K | 11,581 | D | ↗ |
| 2024-09-12 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 5,303 | 0.38 | 2.0K | 10,295 | — | ↗ |
| 2024-02-08 | Prasad Priya | Director / Officer | S-Sale | D | Class A Common Stock | 500 | 7.50 | 3.8K | 4,992 | — | ↗ |
| 2023-12-21 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 1 | 1.18 | 1.18 | 5,492 | — | ↗ |
| 2023-12-14 | Syed Feroz | 10% Owner | P-Purchase | A | Class A Common Stock | 175 | 1.42 | 248.50 | 1,825 | — | ↗ |
| 2023-12-14 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 294 | 1.31 | 385.14 | 3,730 | — | ↗ |
| 2023-12-13 | Syed Feroz | 10% Owner | P-Purchase | A | Class A Common Stock | 200 | 1.36 | 272.00 | 1,650 | — | ↗ |
| 2023-12-13 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 647 | 1.40 | 905.80 | 3,436 | — | ↗ |
| 2023-12-12 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 425 | 1.40 | 595.00 | 2,789 | — | ↗ |
| 2023-12-11 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 362 | 1.37 | 495.94 | 2,364 | — | ↗ |
| 2023-12-08 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 50 | 1.23 | 61.50 | 5,491 | — | ↗ |
| 2023-12-08 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 193 | 1.30 | 250.90 | 2,002 | — | ↗ |
| 2023-12-07 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 10 | 1.22 | 12.20 | 5,441 | — | ↗ |
| 2023-12-07 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 206 | 1.27 | 261.62 | 1,809 | — | ↗ |
| 2023-12-06 | Syed Feroz | 10% Owner | P-Purchase | A | Class A Common Stock | 200 | 1.33 | 266.00 | 1,450 | — | ↗ |
| 2023-12-06 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 50 | 1.22 | 61.00 | 5,431 | — | ↗ |
| 2023-12-06 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 398 | 1.29 | 513.42 | 1,603 | — | ↗ |
| 2023-12-05 | Syed Feroz | 10% Owner | P-Purchase | A | Class A Common Stock | 320 | 1.34 | 428.80 | 1,250 | — | ↗ |
| 2023-12-05 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 10 | 1.21 | 12.10 | 7,381 | — | ↗ |
| 2023-12-05 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 1,145 | 1.32 | 1.5K | 1,205 | — | ↗ |
| 2023-12-04 | Vuppalanchi Deepika | Director / Officer | P-Purchase | A | Class A Common Stock | 426 | 1.17 | 498.42 | 426 | — | ↗ |
| 2023-12-04 | Syed Feroz | 10% Owner | P-Purchase | A | Class A Common Stock | 220 | 1.14 | 250.80 | 930 | — | ↗ |
| 2023-12-04 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 4,271 | 1.14 | 4.9K | 8,106 | — | ↗ |
| 2023-12-01 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 435 | 1.23 | 535.05 | 3,835 | — | ↗ |
| 2023-11-28 | Syed Feroz | 10% Owner | P-Purchase | A | Class A Common Stock | 710 | 1.32 | 937.20 | 710 | — | ↗ |
| 2023-11-28 | Allam Sandeep | Director / Officer | P-Purchase | A | Class A Common Stock | 60 | 1.22 | 73.20 | 60 | — | ↗ |
| 2023-10-09 | Rogers Sherron | Director | A-Award | A | Stock Options | 10,000 | 2.68 | 26.8K | 10,000 | — | ↗ |
| 2023-10-09 | Reddy Vijayapal | Director | A-Award | A | Stock Options | 10,000 | 2.68 | 26.8K | 10,000 | — | ↗ |
| 2023-10-09 | Reddy Avutu | Director | A-Award | A | Stock Options | 10,000 | 2.68 | 26.8K | 10,000 | — | ↗ |
| 2023-10-09 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 1,000 | 2.66 | 2.7K | 3,400 | — | ↗ |
| 2023-10-09 | Paranjape Ketan | Director | A-Award | A | Stock Options | 10,000 | 2.68 | 26.8K | 10,000 | — | ↗ |
| 2023-10-09 | Dahlem Andrew | Director | A-Award | A | Stock Options | 10,000 | 2.68 | 26.8K | 10,000 | — | ↗ |
| 2023-10-05 | Prasad Priya | Director / Officer | S-Sale | D | Class A Common Stock | 918 | 3.19 | 2.9K | 2,400 | — | ↗ |
| 2023-10-03 | Rogers Sherron | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-03 | Reddy Vijayapal | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-03 | Reddy Avutu | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-03 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock Warrants (right to buy) | 2,400 | 6.50 | 15.6K | 2,400 | — | ↗ |
| 2023-10-03 | Paranjape Ketan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-10-03 | Dahlem Andrew | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-29 | Prasad Priya | Director / Officer | P-Purchase | A | Class A Common Stock | 918 | 3.30 | 3.0K | 918 | — | ↗ |
| 2023-09-28 | SLS GROUP LLC | 10% Owner | — | D | Class A Common Stock | 0 | 0.00 | — | 512,500 | — | ↗ |
| 2023-09-26 | Vuppalanchi Deepika | Director / Officer | — | D | Class B Common Stock | 0 | 0.00 | — | 250,000 | — | ↗ |
| 2023-09-26 | Syed Feroz | 10% Owner | — | D | Class B Common Stock | 0 | 0.00 | — | 175,000 | — | ↗ |
| 2023-09-26 | Prasad Priya | Officer / 10% Owner | — | D | Class B Common Stock | 175,000 | 0.00 | — | 0 | — | ↗ |
| 2023-09-26 | Allam Sandeep | Director / Officer | — | D | Class B Common Stock | 0 | 0.00 | — | 233,334 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-15.9K
Shares Outstanding
11.34M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Deepika Vuppalanchi, Former Chief Executive Officer | 271.9K | — | — | — | — | 10.9K | 282.8K | 0.00% | ↗ |
| 2 | 2024 | Sandeep Allam, Former President and Chairman | 193.0K | — | — | — | — | 7.7K | 200.7K | 0.00% | ↗ |
| 3 | 2024 | Priya Prasad, Chief Operating Officer, Chief Financial Officer | 164.7K | — | — | — | — | 6.6K | 171.3K | 0.00% | ↗ |
| 4 | 2023 | Deepika Vuppalanchi, Chief Executive Officer | 307.3K | — | — | — | — | 12.3K | 319.6K | 0.00% | ↗ |
| 5 | 2023 | Deepika Vuppalanchi, Former Chief Executive Officer | 307.3K | — | — | — | — | 12.3K | 319.6K | 0.00% | ↗ |
| 6 | 2023 | Sandeep Allam, Former President and Chairman | 218.1K | — | — | — | — | 8.1K | 226.2K | 0.00% | ↗ |
| 7 | 2023 | Sandeep Allam, President and Chairman | 218.1K | — | — | — | — | 8.1K | 226.2K | 0.00% | ↗ |
| 8 | 2023 | Priya Prasad, Chief Operating Officer, Chief Financial Officer | 147.1K | — | — | — | — | 6.1K | 153.3K | 0.00% | ↗ |
| 9 | 2022 | Deepika Vuppalanchi, Chief Executive Officer | 279.6K | — | — | — | — | 6.5K | 286.2K | 0.00% | ↗ |
| 10 | 2022 | Sandeep Allam, President and Chairman | 180.4K | — | — | — | — | 3.9K | 184.3K | 0.00% | ↗ |
| 11 | 2022 | Priya Prasad, Chief Operating Officer, Chief Financial Officer | 119.6K | — | — | — | — | 2.7K | 122.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Priya Prasad | Chief Financial Officer, Chief Operating Officer & Director | 273.0K | female |
| Christine Drury | IR/PR, Communications & Marketing Director | — | female |
| Feroz Syed | Principal Stockholder of STLHoldings Corporation | — | — |
| Gregory R. Alexander | Chief Executive Officer | — | male |
| Jacop Lucas | Senior Executive Director of People & Operations | — | male |
ESG Rating
ESG Score History MEDICAL - CARE FACILITIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SYRA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
